102
Participants
Start Date
November 15, 2021
Primary Completion Date
September 7, 2023
Study Completion Date
September 7, 2023
Mexidol
Neuroretinoprotector
Placebo
Placebo therapy
"Federal State Budgetary Educational Institution of Higher Education Moscow State Medical and Dental Institute named after A.I. Evdokimov of the Ministry of Health of the RF", Moscow
"Federal State Autonomous Institution Intersectoral Scientific and Technical Complex Eye Microsurgery named after Academician S.N. Fedorov of the Ministry of Health of the RF", Moscow
"State Budgetary Institution of Healthcare of the Yaroslavl Region Clinical Hospital No. 2", Yaroslavl
"Saint Petersburg State Budgetary Healthcare Institution State Hospital No. 40 of the Kurortny District", Saint Petersburg
"Private healthcare institution Clinical hospital RZhD-Medicine of the city of Saratov", Saratov
"Kirov Regional State Budgetary Healthcare Institution Kirov Clinical Ophthalmological Hospital", Kirov
"Budgetary healthcare institution of the Omsk region V.P. Vyhodtsev Clinical Ophthalmological Hospital", Omsk
Lead Sponsor
Pharmasoft
INDUSTRY